Journal of the Korean Academy of Child and Adolescent Psychiatry

Korean Academy of Child and Adolescent Psychiatry (대한소아청소년정신의학회)
권호 표지
DOI QR코드

DOI QR Code

History of the Task Force for the Korean Clinical Guidelines of the Developmental Disorders

  • Bung-Nyun Kim (Division of Children and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Hospital) ;
  • Joung-Sook Ahn (Department of Psychiatry, Yonsei University Wonju College of Medicine)
  • Received : 2023.03.21
  • Accepted : 2023.12.03
  • Published : 2024.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Under the Ministry of Health and Welfare of the Republic of Korea, the National Autism and Developmental Disorder Centers for people with developmental disabilities are gradually expanding. The headquarters of the National Autism and Developmental Disorder Center provides support for education, training, and research, and several centers have been effectively operating since 2020. This study aimed to provide practical recommendations and guidelines for specialists such as clinical psychologists, child psychiatrists, allied professionals, community workers, and related administrators. It was developed as a guideline to promote early diagnosis, provide important information on integrated treatment, and assist people with developmental disabilities in Korea to make the best decisions for their quality of life.

Keywords

Acknowledgement

This study was supported by the Ministry of Health and Welfare, Behavior and Development Center, and the Headquarters of the National Autism and Developmental Disorder Centers.

References

  1. Ahn JS, Koo YJ, Son JW, Yoo HK, Yoo HJ, Chung US, et al. The Korean practice parameter for the treatment of pervasive developmental disorders : development and Implications. J Korean Acad Child Adolesc Psychiatry 2007;18:85-87.
  2. Yoo HI, Cho IH, Yoo HJ, Koo YJ, Chung US, Ahn JS, et al. The Korean practice parameter for the treatment of pervasive developmental disorders : clinical manifestation, epidemiology, course, causes, and comorbidity. J Korean Acad Child Adolesc Psychiatry 2007;18:88-96.
  3. Yoo HJ, Cho IH, Koo YJ, Yoo HI, Son JW, Chung US, et al. The Korean practice parameter for the treatment of pervasive developmental disorders : diagnosis and assessment. J Korean Acad Child Adolesc Psychiatry 2007;18:97-108.
  4. Cho IH, Yoo HK, Son JW, Yoo HJ, Koo YJ, Chung US, et al. The Korean practice parameter for the treatment of pervasive developmental disorders : pharmacological treatment. J Korean Acad Child Adolesc Psychiatry 2007;18:109-116.
  5. Koo YJ, Cho IH, Yoo HJ, Yoo HIK, Son JW, Chung US, et al. The Korean practice parameter for the treatment of pervasive developmental disorders : non-pharmacological treatment. J Korean Acad Child Adolesc Psychiatry 2007;18:117-122.
  6. Lee YK, Shin ES, Shim JY, Min KJ, Kim JM, Lee SH, et al. Developing a scoring guide for the appraisal of guidelines for research and evaluation II instrument in Korea: a modified Delphi consensus process. J Korean Med Sci 2013;28:190-194. https://doi.org/10.3346/jkms.2013.28.2.190
  7. Oh MK, Jo H, Lee YK. Improving the reliability of clinical practice guideline appraisals: effects of the Korean AGREE II scoring guide. J Korean Med Sci 2014;29:771-775. https://doi.org/10.3346/jkms.2014.29.6.771
  8. Jo MW, Lee JY, Kim NS, Kim SY, Sheen S, Kim SH, et al. Assessment of the quality of clinical practice guidelines in Korea using the AGREE instrument. J Korean Med Sci 2013;28:357-365. https://doi.org/10.3346/jkms.2013.28.3.357
  9. Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The guideLine implementability appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak 2005;5:23.
  10. Wang Z, Norris SL, Bero L. The advantages and limitations of guideline adaptation frameworks. Implement Sci 2018;13:72.
  11. Fervers B, Burgers JS, Voellinger R, Brouwers M, Browman GP, Graham ID, et al. Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation. BMJ Qual Saf 2011;20:228-236. https://doi.org/10.1136/bmjqs.2010.043257
  12. Kim BN, Kim YN. Guideline of problematic behavior treatment for children and adolescents with developmental disorder. 1st ed. Seoul: Ministry of Health and Welfare;2018.
  13. Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M, et al. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2014;53:237-257. https://doi.org/10.1016/j.jaac.2013.10.013
  14. New York State Department of Health. Clinical practice guideline on assessment and intervention services for young children with autism spectrum disorders (ASD): 2017 update [Internet]. Albany, NY: New York State Department of Health [cited 2022 Nov 3]. Available from: https://www.health.ny.gov/publications/20152.pdf.
  15. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: recognition, referral and diagnosis [Internet]. Manchester: National Institute for Health and Care Excellence [cited 2022 Oct 10]. Available from: https://www.nice.org.uk/guidance/cg128/resources/autism-spectrum-disorder-inunder-19s-recognition-referral-and-diagnosispdf-35109456621253.
  16. National Institute for Health and Care Excellence. Autism spectrum disorder in adults: diagnosis and management [Internet]. Manchester: National Institute for Health and Care Excellence [cited 2022 Sep 15]. Available from: https://www.nice.org.uk/guidance/cg142/resources/autism-spectrum-disorder-in-adults-diagnosis-and-management-pdf-35109567475909.
  17. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: support and management [Internet]. Manchester: National Institute for Health and Care Excellence [cited 2022 Sep 1]. Available from: https://www.nice.org.uk/guidance/cg170/resources/autism-spectrum-disorder-in-under-19s-support-and-management-pdf-35109745515205.
  18. Scottish Intercollegiate Guidelines Network. Assessment, diagnosis and interventions for autism spectrum disorders: a national clinical guideline (SIGN 145) [Internet]. Edinburgh: Scottish Intercollegiate Guidelines Network [cited 2022 Dec 7]. Available from: https://www.sign.ac.uk/media/1081/sign145.pdf.
  19. Fuentes J, Hervas A, Howlin P; ESCAP ASD Working Party. ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment. Eur Child Adolesc Psychiatry 2021;30:961-984. https://doi.org/10.1007/s00787-020-01587-4
  20. Treweek S, Oxman AD, Alderson P, Bossuyt PM, Brandt L, Brozek J, et al. Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results. Implement Sci 2013;8:6.
  21. Ministry of Health and Welfare. The abolition of grades of disabilities [Internet]. Sejong: Ministry of Health and Welfare [cited 2022 Oct 23]. Available from: https://www.law.go.kr/행정규칙/장애등급판정기준/(2017-65,20170413).
  22. Thurm A, Farmer C, Salzman E, Lord C, Bishop S. State of the field: differentiating intellectual disability from autism spectrum disorder. Front Psychiatry 2019;10:526.
  23. Casanova EL, Sharp JL, Chakraborty H, Sumi NS, Casanova MF. Genes with high penetrance for syndromic and non-syndromic autism typically function within the nucleus and regulate gene expression. Mol Autism 2016;7:18.
  24. Polyak A, Kubina RM, Girirajan S. Comorbidity of intellectual disability confounds ascertainment of autism: implications for genetic diagnosis. Am J Med Genet B Neuropsychiatr Genet 2015;168:600-608. https://doi.org/10.1002/ajmg.b.32338